Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Bliss GVS Pharma Ltd - 506197 - Board Meeting Intimation for Approval Of Mentioned Agendas

 BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/02/2019 ,inter alia, to consider and approve the following agendas: a) The proposal for establishment of Employee Stock Option Plan scheme; b) Increase in Shareholding limit of Foreign Portfolio Investors in the Company; and c) Re-appointment and continuation of Directorship of Mr. S. R. Vaidya (DIN: 03600249) as an Independent Director of the Company. Kindly acknowledge and take on record the same.
19-02-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Polus Global Fund
11-02-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Narsimha Shibroor Kamath
06-02-2019

Promoters sell shares in Bliss GVS, Polus Global Fund picks up 8%

 Multiple promoter and promoter group entities in Bliss GVS Pharma have sold shares over the past week on the market via insider trades. This included a share sale by Promoter Director Narasimha Kamath, who sold 3.55% of total shares on the market for an average price of Rs. 152.8. The company is currently trading at Rs. 160 share price on the stock market. Also selling off Bliss shares were three other promoter group or promoter-directors. In all, 10.6% of Bliss GVS shares were disposed of in the market. FII Polus Global Fund has acquired 8.04% of the company via an SAST transaction.
05-02-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Polus Global Fund
01-02-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Loss of Share Certificate / Issue of Duplicate Share Certificate

 Bliss GVS Pharma Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate.
01-02-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Enclosed herewith investor presentation on Company's performance for the quarter and nine months ended December 31, 2018. Kindly take the same on record.
01-02-2019
Bigul

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to the provisions of Regulation 47(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the extract copies of newspaper advertisement clippings of unaudited financial results of the Company for the quarter and nine months ended December 31, 2018 published in 'The Economic Times & The Free Press Journal' an English Daily and 'Maharashtra Times & Navshkati' a Regional Daily, on January 31, 2019. Kindly take the same on record.
31-01-2019
Bigul

BLISS GVS PHARMA LTD. - 506197 - Standalone & Consolidated Unaudited Financial Results For The Quarter & Nine Months Ended December 31, 2018

 We like to inform you that Board Meeting of the Company was held today i.e. on Tuesday, January 29, 2019 at 4.00 P.M. at the registered office of the Company. The Board has considered and approved in pursuant to Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 the following: 1. The unaudited financial results (both standalone & consolidated) for the quarter ended December 31, 2018. A coy of approved unaudited financial results of the Company along with Limited Review Report of the Auditors of the Company on the said results are enclosed. 2. BDO India LLP have been appointed as the Internal Auditor of the Company. 3. The decision on the Employee Stock Option Plan scheme have been deferred till the next board meeting. The meeting of the Board of Directors commenced at 4.00 p.m. and concluded at 8:45 p.m. Kindly take the same on record.
29-01-2019
Bigul

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Please find enclosed herewith the copy of the newspaper advertisement of notice of Board Meeting of the Company will be held on Tuesday, January 29, 2019 at the registered office of the Company at 4.00 p.m., inter-alia, to consider and approve the agenda published in 'The Economic Times & The Free Press Journal' an English Daily and 'Maharashtra Times & Navshkati' a Regional Daily, on January 22, 2019. Kindly take the same on record.
24-01-2019
Next Page
Close

Let's Open Free Demat Account